![]() |
Volumn 40, Issue 9, 2008, Pages 3166-3169
|
Use of Everolimus in De Novo Renal Recipients: Initial Experience in the Greek Population
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
BASILIXIMAB;
CORTICOSTEROID;
CREATININE;
CYCLOSPORIN A;
EVEROLIMUS;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
ARTICLE;
ATELECTASIS;
CATHETER INFECTION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
CREATININE CLEARANCE;
CYTOMEGALOVIRUS INFECTION;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG FATALITY;
DRUG USE;
GRAFT RECIPIENT;
GRAFT VERSUS HOST REACTION;
GREECE;
HUMAN;
HYPERTENSION;
KIDNEY CLEARANCE;
KIDNEY FUNCTION;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LEUKOPENIA;
PRIORITY JOURNAL;
PYREXIA IDIOPATHICA;
THROMBOCYTOPENIA;
URINARY TRACT INFECTION;
WOUND DEHISCENCE;
WOUND INFECTION;
ADRENAL CORTEX HORMONES;
ANTIBODIES, MONOCLONAL;
CREATININE;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MYCOPHENOLIC ACID;
RECOMBINANT FUSION PROTEINS;
RETROSPECTIVE STUDIES;
SIROLIMUS;
|
EID: 56049123703
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2008.09.038 Document Type: Article |
Times cited : (2)
|
References (8)
|